These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34172447)

  • 1. Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test.
    Heggestad JT; Kinnamon DS; Olson LB; Liu J; Kelly G; Wall SA; Oshabaheebwa S; Quinn Z; Fontes CM; Joh DY; Hucknall AM; Pieper C; Anderson JG; Naqvi IA; Chen L; Que LG; Oguin T; Nair SK; Sullenger BA; Woods CW; Burke TW; Sempowski GD; Kraft BD; Chilkoti A
    Sci Adv; 2021 Jun; 7(26):. PubMed ID: 34172447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed, quantitative serological profiling of COVID-19 from a drop of blood by a point-of-care test.
    Heggestad JT; Kinnamon DS; Olson LB; Liu J; Kelly G; Wall SA; Fontes CM; Joh DY; Hucknall AM; Pieper C; Naqvi IA; Chen L; Que LG; Oguin T; Nair SK; Sullenger BA; Woods CW; Sempowski GD; Kraft BD; Chilkoti A
    medRxiv; 2020 Nov; ():. PubMed ID: 33173900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Kruse RL; Huang Y; Smetana H; Gehrie EA; Amukele TK; Tobian AAR; Mostafa HH; Wang ZZ
    Biochem Biophys Res Commun; 2021 May; 553():165-171. PubMed ID: 33773139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2.
    Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34072890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of spike protein antigens for SARS-CoV-2 serology.
    Jagtap S; K R; Valloly P; Sharma R; Maurya S; Gaigore A; Ardhya C; Biligi DS; Desiraju BK; Natchu UCM; Saini DK; Roy R
    J Virol Methods; 2021 Oct; 296():114222. PubMed ID: 34197839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins.
    Zhang P; Gao Q; Wang T; Ke Y; Mo F; Jia R; Liu W; Liu L; Zheng S; Liu Y; Li L; Wang Y; Xu L; Hao K; Min W; Liu X; Yang R; Li S; Lin C; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):921-928. PubMed ID: 33184753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method.
    Nguyen KD; Wirz OF; Röltgen K; Pandey S; Tolentino L; Boyd SD; Pham TD
    Arch Pathol Lab Med; 2021 Oct; 145(10):1221-1227. PubMed ID: 34101801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
    Ogata AF; Maley AM; Wu C; Gilboa T; Norman M; Lazarovits R; Mao CP; Newton G; Chang M; Nguyen K; Kamkaew M; Zhu Q; Gibson TE; Ryan ET; Charles RC; Marasco WA; Walt DR
    Clin Chem; 2020 Dec; 66(12):1562-1572. PubMed ID: 32897389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP.
    Keshavarz B; Wiencek JR; Workman LJ; Straesser MD; Muehling LM; Canderan G; Drago F; Bonham CA; Sturek JM; Ramani C; McNamara CA; Woodfolk JA; Kadl A; Platts-Mills TAE; Wilson JM
    Int Arch Allergy Immunol; 2021; 182(5):417-424. PubMed ID: 33621972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.
    Angeloni S; Cameron A; Pecora ND; Dunbar S
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33900295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies.
    Krähling V; Halwe S; Rohde C; Becker D; Berghöfer S; Dahlke C; Eickmann M; Ercanoglu MS; Gieselmann L; Herwig A; Kupke A; Müller H; Neubauer-Rädel P; Klein F; Keller C; Becker S
    J Immunol Methods; 2021 Mar; 490():112958. PubMed ID: 33412174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.